True resistant hypertension is relatively frequent, yet effective treatment is often difficult to
identify. In a new study, de Souza and colleagues demonstrate the potent blood pressure
lowering effect of low-dose spironolactone in patients with evident resistant hypertension.
This finding should have broad clinical implications in the effective management of a
notoriously challenging condition.